摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(oxan-2-yloxy)-2-piperazin-1-ylpyrimidine-5-carboxamide | 875138-65-1

中文名称
——
中文别名
——
英文名称
N-(oxan-2-yloxy)-2-piperazin-1-ylpyrimidine-5-carboxamide
英文别名
——
N-(oxan-2-yloxy)-2-piperazin-1-ylpyrimidine-5-carboxamide化学式
CAS
875138-65-1
化学式
C14H21N5O3
mdl
——
分子量
307.352
InChiKey
AXSWIRZOOZCOEC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    88.6
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • HDAC INHIBITING DERIVATIVES OF CAMPTOTHECIN
    申请人:Chen Yi
    公开号:US20130281402A1
    公开(公告)日:2013-10-24
    The disclosure includes hydroxamic compounds of Formula I: (Formula I) wherein Z, L, R 1 , R 2 , and R 3 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
    本公开涉及式I的羟肟酰胺化合物:(式I),其中Z,L,R1,R2和R3的定义如本文所述。还公开了使用这些化合物治疗肿瘤性疾病或免疫性疾病的方法。
  • WO2007/82880
    申请人:——
    公开号:——
    公开(公告)日:——
  • Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors
    作者:Patrick Angibaud、Kristof Van Emelen、Laurence Decrane、Sven van Brandt、Peter ten Holte、Isabelle Pilatte、Bruno Roux、Virginie Poncelet、David Speybrouck、Laurence Queguiner、Sandrine Gaurrand、Ann Mariën、Wim Floren、Lut Janssen、Marc Verdonck、Jacky van Dun、Jacky van Gompel、Ron Gilissen、Claire Mackie、Marc Du Jardin、Jozef Peeters、Marc Noppe、Luc Van Hijfte、Eddy Freyne、Martin Page、Michel Janicot、Janine Arts
    DOI:10.1016/j.bmcl.2009.10.118
    日期:2010.1
    Pursuing our efforts in designing 5-pyrimidylhydroxamic acid anti-cancer agents, we have identified a new series of potent histone deacetylase (HDAC) inhibitors. These compounds exhibit enzymatic HDAC inhibiting properties with IC50 values in the nanomolar range and inhibit tumor cell proliferation at similar levels. Good solubility, moderate bioavailability, and promising in vivo activity in xenograft model made this series of compounds interesting starting points to design new potent HDAC inhibitors. (c) 2009 Elsevier Ltd. All rights reserved.
  • SUBSTITUTED PROPENYL PIPERAZINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE
    申请人:Van Brandt Anna Sven Franciscus
    公开号:US20070135424A1
    公开(公告)日:2007-06-14
    This invention comprises the novel compounds of formula (I) wherein R 1 , R 2 , R 3 , R 4 and X have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
  • Squaric Acid Derivatives as Inhibitors of Histone Deacetylase
    申请人:Van Emelen Kristof
    公开号:US20080255140A1
    公开(公告)日:2008-10-16
    This invention comprises the novel compounds of formula (I) wherein R 1 , R 2 and X have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, compositions containing them and their use as a medicine.
查看更多